3 ms·
Oh hey, funny seeing Valeant in there. I'm actually a bit disappointed to see them only once, with more references to the usual Big Names (Novartis, Bayer, Glax
by AceJohnny2 8y ago
Oh hey, funny seeing Valeant in there. I'm actually a bit disappointed to see them only once, with more references to the usual Big Names (Novartis, Bayer, GlaxoSmithKline...).
For some insight into the business of pharma, may I humbly recommend Derek Lowe's amazing blog In The Pipeline. For example, here's the most recent article of his about Valeant I could find, from last year:
http://blogs.sciencemag.org/pipeline/archives/2017/04/03/bill-ackman-pompey-and-you http://blogs.sciencemag.org/pipeline/archives/2017/04/03/bil...
I first discovered his blog through his series "Things I won't work with", with some hilarious descriptions of very very dangerous chemicals:
http://blogs.sciencemag.org/pipeline/archives/category/things-i-wont-work-with http://blogs.sciencemag.org/pipeline/archives/category/thing...
- aaavl2821 8y agoDerek's blog is great. I also recommend Bruce Booth's lifescivc blog, which is one of the few blogs written by top tier early stage biotech VCs https://lifescivc.com/ https://lifescivc.com/